Premier Alternatives

Swing Therapeutics

San Francisco, CA · Founded 2019 · Privately Held (backing)

Developer of novel prescription digital therapeutics designed to empower people to live joyful and vibrant lives. Swing Therapeutics is based in San Francisco, CA and was founded in 2019. It was valued at $24.3 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $31.4 million across 4 recorded rounds; the latest was a $3.3 million seed round in Aug 2025.

PMV mark · valuation
$24.3M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$31.4M
Last round
Seed Round
Aug 2025

Swing Therapeutics key facts

as of Oct 2026
  • Developer of novel prescription digital therapeutics designed to empower people to live joyful and vibrant lives.
  • Swing Therapeutics is valued at approximately $24.3M as of Oct 2026, set at its later-stage round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $31.4M across 4 recorded rounds; the latest was Seed Round ($3.3M) in Aug 2025.
  • Notable investors include Alumni Ventures, Mana Ventures, Gaingels, Endless Frontier Labs, AME Cloud Ventures — 10 tracked in total.
  • Swing Therapeutics has filed 4 Form Ds with the SEC since 2022, most recently Sep 2025 ($3.3M sold to 1 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$24.3M

Valued at $24.3M at its later-stage round, Aug 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Swing Therapeutics with a free account
  • ·Watch Swing Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Swing Therapeutics funding rounds

4 rounds
Aug 2025Seed Round$3.3MSEC filing▮
May 2025Early Stage VC$11.4MSEC filing▮
Jan 2022Early Stage VC$10.3MSEC filing▮
Aug 2019Early Stage VC$9.2MSEC filing▮
Full funding history →

Swing Therapeutics valuation

Swing Therapeutics was valued at $24.3 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Swing Therapeutics raised?

Swing Therapeutics has raised $31.4 million across 4 recorded rounds since 2019. The largest was a $9.2 million early-stage round in Aug 2019; the most recent was a $3.3 million seed round in Aug 2025.

Swing Therapeutics has filed 4 Form Ds with the SEC since 2022, most recently in Sep 2025 ($3.3 million sold to 1 investor).

Swing Therapeutics investors

10 investors are on record for Swing Therapeutics, including Alumni Ventures, Mana Ventures, Gaingels and Endless Frontier Labs. By type, the record holds 5 venture capital firms. The seed round in Aug 2025 drew 1 investor.

About Swing Therapeutics

Developer of novel prescription digital therapeutics designed to empower people to live joyful and vibrant lives. The company's therapeutics offer evidence-based, transformative digital treatments, enabling patients and clinics to regain control of illnesses.

Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2019
Employees
22
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.